We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
The management, surveillance and epidemiology of carbapenem resistance.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
FCDO travel advice for Colombia. Includes safety and security, insurance, entry requirements and legal differences.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Competent authorities of exporting countries should use the relevant model health certificate as a template to create a version exporters can apply for to export other animal products to Great Britain, the Channel Islands or Isle of Man.
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
HPTs and healthcare practitioners must complete these forms and send them to UKHSA to enable monitoring of diphtheria cases in England.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
How to spot Batrachochytrium salamandrivorans, what to do if you suspect it and measures to prevent its spread.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.